| Predicted Trait | |
| Reported Trait | Inflammatory bowel disease |
| Mapped Trait(s) | inflammatory bowel disease (EFO_0003767) |
| Score Construction | |
| PGS Name | GPS_IBD |
| Development Method | |
| Name | LDpred |
| Parameters | ρ = 0.1; LD panel = 503 1000G Europeans |
| Variants | |
| Original Genome Build | hg19 |
| Number of Variants | 6,907,112 |
| Effect Weight Type | NR |
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000006 |
| Citation (link to publication) | Khera AV et al. Nat Genet (2018) |
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
|---|---|---|---|
GWAS Catalog: GCST003043 Europe PMC: 26192919 |
34,652 individuals | European | NR |
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | Phenotype Definitions & Methods | Age of Study Participants | Participant Follow-up Time | Additional Ancestry Description | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| — | [
|
European | UKB | Inflammatory bowel disease ascertainment was based on report in an interview with a trained nurse, or an ICD-9 code of 555.X or ICD-10 code of K51.X in hospitalization records. | — | — | — | UKB Phase 1 |
|
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|
| PPM000026 | PSS000016| European Ancestry| 288,978 individuals |
PGP000006 | Khera AV et al. Nat Genet (2018) |
Reported Trait: Inflammatory bowel disease | — | AUROC: 0.63 [0.62, 0.64] | Nagelkerke’s R2 (estimate of variance explained by the PGS after covariate adjustment): 0.021 | age; sex; Ancestry PC 1-4; genotyping chip | — |
| PPM012874 | PSS009588| European Ancestry| 1,433 individuals |
PGP000288 | Garcia-Etxebarria K et al. Sci Rep (2022) |Ext. |
Reported Trait: Inflammatory Bowel Disease | — | AUROC: 0.69 [0.66, 0.72] | — | — | — |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS009588 | — | — | [
|
— | European | — | BV | — |
| PSS000016 | Inflammatory bowel disease ascertainment was based on report in an interview with a trained nurse, or an ICD-9 code of 555.X or ICD-10 code of K51.X in hospitalization records. | — | [
|
— | European | — | UKB | UKB Phase 2 |